Stockreport

Better Buy: Editas Medicine or Sangamo Therapeutics? [The Motley Fool]

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF Better Buy: Editas Medicine or Sangamo Therapeutics? These gene-editing trailblazers continue advancing exciting new approaches to treating inherited diseases. Gene edit [Read more]